Weng et al. reported that artemisinin alleviates hyperoxia-induced BPD injury by inhibiting NF-κB pathway activation and inflammatory factor expression (Weng et al., 2024). This evidence concerns the gene NFKB1 and bronchopulmonary dysplasia.